74 results
10-K
2023 FY
EX-10.27
XENE
Xenon Pharmaceuticals Inc
Annual report
29 Feb 24
4:36pm
10-K
2023 FY
EX-10.28
XENE
Xenon Pharmaceuticals Inc
Annual report
29 Feb 24
4:36pm
8-K
EX-10.1
XENE
Xenon Pharmaceuticals Inc
14 Mar 23
Departure of Directors or Certain Officers
4:03pm
8-K
EX-10.1
ko5inxzr5nezb885ge
2 Jun 22
Departure of Directors or Certain Officers
4:03pm
8-K
EX-10.1
x9zc5omams8eh
12 Jan 22
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
8:04am
8-K
EX-10.1
i8pkif
1 Dec 21
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
tbcf5xn wx2ckcyanpx
8 Sep 21
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone
8:32am
8-K
EX-10.1
dlyl7hf 67c
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.4
nor21gq1h85elcvx
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.2
odc4k6q
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.3
k4m fo4c4z6dquxe
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am